BRPI0506751B8 - método para isolar uma fração bioativa derivada de suco celular de uma planta de camellia sinensis - Google Patents

método para isolar uma fração bioativa derivada de suco celular de uma planta de camellia sinensis

Info

Publication number
BRPI0506751B8
BRPI0506751B8 BRPI0506751A BRPI0506751A BRPI0506751B8 BR PI0506751 B8 BRPI0506751 B8 BR PI0506751B8 BR PI0506751 A BRPI0506751 A BR PI0506751A BR PI0506751 A BRPI0506751 A BR PI0506751A BR PI0506751 B8 BRPI0506751 B8 BR PI0506751B8
Authority
BR
Brazil
Prior art keywords
bioactive
present
relates
methods
isolate
Prior art date
Application number
BRPI0506751A
Other languages
English (en)
Portuguese (pt)
Inventor
Koganov Michael
Original Assignee
Akzo Nobel Surface Chemistry Llc
Integrated Botanical Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Surface Chemistry Llc, Integrated Botanical Tech Llc filed Critical Akzo Nobel Surface Chemistry Llc
Publication of BRPI0506751A publication Critical patent/BRPI0506751A/pt
Publication of BRPI0506751B1 publication Critical patent/BRPI0506751B1/pt
Publication of BRPI0506751B8 publication Critical patent/BRPI0506751B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G23/00—Compounds of titanium
    • C01G23/04—Oxides; Hydroxides
    • C01G23/047—Titanium dioxide
    • C01G23/053—Producing by wet processes, e.g. hydrolysing titanium salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B13/00—Oxygen; Ozone; Oxides or hydroxides in general
    • C01B13/14—Methods for preparing oxides or hydroxides in general
    • C01B13/32—Methods for preparing oxides or hydroxides in general by oxidation or hydrolysis of elements or compounds in the liquid or solid state or in non-aqueous solution, e.g. sol-gel process
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09C—TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK  ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
    • C09C1/00—Treatment of specific inorganic materials other than fibrous fillers; Preparation of carbon black
    • C09C1/36—Compounds of titanium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Rheumatology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Hematology (AREA)
  • Geology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0506751A 2004-01-12 2005-01-12 método para isolar uma fração bioativa derivada de suco celular de uma planta de camellia sinensis BRPI0506751B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53586104P 2004-01-12 2004-01-12
US60/535,861 2004-01-12
PCT/US2005/001132 WO2005069835A2 (en) 2004-01-12 2005-01-12 Bioactive compositions from theacea plants and processes for their production and use

Publications (3)

Publication Number Publication Date
BRPI0506751A BRPI0506751A (pt) 2007-06-12
BRPI0506751B1 BRPI0506751B1 (pt) 2019-12-31
BRPI0506751B8 true BRPI0506751B8 (pt) 2021-05-25

Family

ID=34806966

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0506751A BRPI0506751B8 (pt) 2004-01-12 2005-01-12 método para isolar uma fração bioativa derivada de suco celular de uma planta de camellia sinensis

Country Status (13)

Country Link
US (6) US7473435B2 (enExample)
EP (2) EP1722805B1 (enExample)
JP (2) JP5276270B2 (enExample)
KR (1) KR101224697B1 (enExample)
CN (2) CN1929851B (enExample)
AU (2) AU2005206875B2 (enExample)
BR (1) BRPI0506751B8 (enExample)
CA (1) CA2552710A1 (enExample)
ES (2) ES2652603T3 (enExample)
MX (2) MXPA06007942A (enExample)
NZ (2) NZ598539A (enExample)
PL (1) PL1722805T3 (enExample)
WO (1) WO2005069835A2 (enExample)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8277852B2 (en) * 2002-01-25 2012-10-02 Akzo Nobel Surface Chemistry Llc Bioactive botanical cosmetic compositions and processes for their production
CA2643255A1 (en) * 2006-02-21 2007-08-30 Integrated Botanical Technologies, Llc Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production
JP5624764B2 (ja) * 2007-07-13 2014-11-12 小川香料株式会社 香味又は香気の劣化抑制剤
EP2211630B1 (en) * 2007-11-05 2012-08-01 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Process for manufacturing tea products
AU2008324227B2 (en) * 2007-11-05 2012-03-08 Ekaterra Research and Development UK Limited Process for manufacturing tea products
PL2211632T3 (pl) * 2007-11-05 2011-08-31 Unilever Nv Sposób oczyszczania związków pochodzących z herbaty
US20090202676A1 (en) * 2008-02-07 2009-08-13 Conopco, Inc. D/B/A Unilever Process for manufacturing a tea product
CN102164500B (zh) * 2008-10-02 2014-08-20 荷兰联合利华有限公司 生产茶产品的方法
PL2334192T3 (pl) * 2008-10-02 2013-01-31 Unilever Nv Sposób wytwarzania herbacianych produktów
JP5287524B2 (ja) * 2009-06-05 2013-09-11 東京電力株式会社 植物系バイオマスの多元的有効利用システム
BR112012010978A8 (pt) * 2009-11-11 2018-06-26 Akzo Nobel Surface Chemistry Llc método para produzir um organismo fotossintético induzido por estresse, organismo fotossintético induzido por estresse, método para isolar uma fração bioativa alterada de um organismo fotossintético induzido por estresse, fração bioativa alterada, formulação tópica bioativa adequada para aplicação tópica em um mamifero, método para inibir a atividade inflamatória no tecido da pele de um mamífero, método de proteger o tecido da pele de um mamífero dos danos induzidos por luz ultravioleta, método para normalizar os distúrbios da pele no tecido da pele de um mamífero, e, sistema para cultivar organismos fotossintéticos induzidos por estresse
US9962326B2 (en) 2010-08-19 2018-05-08 Johnson & Johnson Consumer Inc. Compositions comprising paulownia tomentosa wood extracts and uses thereof
US9168279B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising paulownin and/or Paulownia extracts and uses thereof
US9168219B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9387349B2 (en) 2010-08-19 2016-07-12 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9168207B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
KR20130099058A (ko) 2010-08-19 2013-09-05 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 파울로우닌 및/또는 파울로우니아 추출물을 포함하는 조성물 및 이의 용도
US9173913B2 (en) 2010-08-19 2015-11-03 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9161958B2 (en) 2010-08-19 2015-10-20 Johnson & Johnson Consumer Inc. Methods of treating cellulite
US20120201768A1 (en) * 2010-09-10 2012-08-09 Cheri Lynn Swanson Cosmetic compositions comprising ficus serum fraction and methods to reduce the appearance of skin hyperpigmentation
US8895628B2 (en) 2010-10-25 2014-11-25 Johnson & Johnson Consumer Companies, Inc. Compositions comprising a retinoid and an NFkB-inhibitor and their methods of use
US9421236B2 (en) 2010-12-17 2016-08-23 Johnson & Johnson Consumer Inc. Compositions comprising Lilium siberia extracts and uses thereof
EP2465490A3 (en) 2010-12-17 2015-06-17 Johnson & Johnson Consumer Companies Inc. Compositions comprising Lilium Siberia extracts and uses thereof
ES2692536T3 (es) 2010-12-17 2018-12-04 Johnson & Johnson Consumer Inc. Composiciones que comprenden extractos de Lilium martagon y usos de los mismos
US8486466B2 (en) 2010-12-17 2013-07-16 Johnson & Johnson Consumer Companies, Inc. Compositions comprising Lilium siberia extracts and uses thereof
EP2465518B1 (en) 2010-12-17 2016-03-02 Johnson & Johnson Consumer Companies Inc. Compositions Comprising Lilium Candidum Extracts and Uses Thereof
US8293293B2 (en) 2010-12-17 2012-10-23 Johnson & Johnson Consumer Companies, Inc. Compositions comprising Lilium martagon extracts and uses thereof
US8481093B2 (en) * 2010-12-17 2013-07-09 Johnson & Johnson Consumer Companies, Inc. Compositions comprising Lilium candidum extracts and uses thereof
US9492492B2 (en) 2010-12-17 2016-11-15 Johnson & Johnson Consumer Inc. Compositions comprising Lilium martagon extracts and uses thereof
US20130149359A1 (en) * 2011-12-12 2013-06-13 Eric M. Sanders Effervescent Mouthwash
JP5860166B2 (ja) * 2011-12-22 2016-02-16 ザ プロクター アンド ギャンブルカンパニー 皮膚の処置のための組成物及び方法
KR20140107325A (ko) * 2011-12-22 2014-09-04 아크조 노벨 케미칼즈 인터내셔널 비.브이. 피부 항노화 활성을 가진 생활성 조성물
BR112014014572A8 (pt) * 2011-12-22 2017-06-13 Akzo Nobel Chemicals Int Bv composição bioativa
EP2794011B1 (en) 2011-12-22 2016-12-14 The Procter and Gamble Company Compositions and methods for improving the appearance of aging hair
US9814659B2 (en) 2012-04-02 2017-11-14 Johnson & Johnson Consumer Inc. Methods of lightening the skin
US20140086859A1 (en) 2012-09-24 2014-03-27 Johnson & Johnson Consumer Companies, Inc. Low oil compositions comprising a 4-substituted resorcinol and a high carbon chain ester
ES2606024T3 (es) * 2012-11-14 2017-03-17 Isp Investments Inc. Un método para la preparación de composiciones botánicas bioactivas y las composiciones hechas a partir de dicho método utilizando un campo electromagnético de más de 3 GHz
KR101474998B1 (ko) * 2012-11-28 2014-12-19 롯데푸드 주식회사 피부 주름 생성 억제 및 주름 개선 활성을 갖는 백차 추출물을 함유하는 조성물
SG11201506037WA (en) * 2013-02-08 2015-08-28 Akzo Nobel Chemicals Int Bv Bioactive compositions from theacea plants and use thereof in beverages, functional foods, nutriceuticals, supplements and the like
SG11201506444RA (en) * 2013-03-13 2015-09-29 Akzo Nobel Chemicals Int Bv Bioactive botanical compositions and uses thereof
WO2014158679A1 (en) * 2013-03-14 2014-10-02 Avon Products, Inc Eurya groffii extracts and methods of use
US9579278B2 (en) 2013-05-10 2017-02-28 Johnson & Johnson Consumer Inc. Compositions comprising extracts of Bursera simaruba
US10123966B2 (en) 2013-05-16 2018-11-13 The Procter And Gamble Company Hair thickening compositions and methods of use
EP2829303A1 (en) 2013-07-22 2015-01-28 Johnson & Johnson Consumer Companies Inc. Compositions comprising extract of malva neglecta and method of treating a skin condition with malva neglecta
US9522168B2 (en) 2014-05-29 2016-12-20 Johnson & Johnson Consumer Inc. Topical compositions comprising Acmella oleracea extracts and uses thereof
JP6587678B2 (ja) * 2014-08-01 2019-10-09 シャネル パフュームズ ビューテ ツバキ（Ｃａｍｅｌｌｉａ ｊａｐｏｎｉｃａ）抽出物およびそれを含有する化粧品組成物
BR112017021328A2 (pt) * 2015-04-07 2018-06-26 Xyleco Inc métodos de monitoramento e sistemas para processamento de biomassa
CN106691902B (zh) 2015-08-14 2021-04-20 强生消费者公司 包含显齿蛇葡萄和合欢提取物的组合物和使用方法
WO2017100430A1 (en) * 2015-12-08 2017-06-15 Isp Investments Llc Bioactive compositions from achachairu (garcinia humilis) and methods for their production
KR101723526B1 (ko) * 2016-02-22 2017-04-06 주식회사 젠퓨어 동백꽃, 벚꽃, 쟈스민꽃, 캐모마일꽃 및 연꽃 혼합추출물을 함유하는 화장료 조성물
US11154493B2 (en) * 2016-02-25 2021-10-26 Isp Investments Llc Mitigating adverse effects of sunlight with ingredients obtained from living plants
KR101769110B1 (ko) 2016-02-29 2017-08-17 전라남도 난대 산림수종의 산림욕 성분의 최적 추출 방법 및 그에 따라 제조된 난대 산림수종의 향기 추출물
US10806693B2 (en) 2016-09-07 2020-10-20 Isp Investments Llc Method for increasing lipolysis using a composition comprising bioactive Nelumbo nucifera (lotus) extract
US10056362B2 (en) 2016-10-06 2018-08-21 Infineon Technologies Americas Corp. Multi-phase power converter with common connections
US10204847B2 (en) 2016-10-06 2019-02-12 Infineon Technologies Americas Corp. Multi-phase common contact package
CN107227289B (zh) * 2017-05-08 2020-05-22 广州赛莱拉干细胞科技股份有限公司 一种山茶花细胞提取物及其提取方法和应用
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
CN112888450A (zh) 2018-07-27 2021-06-01 强生外科视力公司 用于治疗眼睛的组合物和方法
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US20200030226A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Consumer Inc. Botanical and bacterial extracts displaying retinol-like activity
JP7374986B2 (ja) 2018-07-27 2023-11-07 ジョンソン・アンド・ジョンソン・サージカル・ビジョン・インコーポレイテッド 眼を治療するための組成物及び方法
WO2021011548A1 (en) 2019-07-15 2021-01-21 Isp Investments Llc Skin care compositions comprising synergistic blend of sacred lotus and tea plant or sacred lotus and german chamomile and cosmetic applications thereof
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
EP3824895A1 (en) 2019-11-19 2021-05-26 Johnson & Johnson Consumer Inc. Compositions and methods for treating the eye
US20210299203A1 (en) 2020-03-26 2021-09-30 Johnson & Johnson Consumer Inc. Compositions comprising carum carvi and rosmarinus officinalis extracts and methods of using same
JP7771499B2 (ja) 2020-03-26 2025-11-18 ケンビュー・ブランズ・エルエルシー ヒメウイキョウおよびローズマリー抽出物を含む組成物、並びにそれらを使用する方法
EP4059508A1 (en) 2021-03-19 2022-09-21 Johnson & Johnson Consumer Inc. Methods of using compositions comprising an iceland moss extract
WO2023114279A1 (en) 2021-12-17 2023-06-22 Isp Investments Llc Bioactive serum fractions from fresh rose flowers and methods for their preparation and uses
FR3130619B1 (fr) 2021-12-17 2025-10-31 Lvmh Rech Fraction bioactive isolée de roses de la variété Evanrat
FR3136172B1 (fr) 2022-06-07 2025-07-11 Lvmh Rech Composition anti-âge avec extraits de rose et peptides
FR3137836A1 (fr) 2022-07-13 2024-01-19 L V M H Recherche Fraction bioactive isolée de roses de la variété Evanrat pour une utilisation cosmétique apaisante de la peau et/ou des lèvres
FR3143365A1 (fr) 2022-12-19 2024-06-21 L V M H Recherche Composition anti-age avec extraits de bourgeons et petales de roses et peptide
JP2026504051A (ja) 2023-01-11 2026-02-03 ケンビュー・ブランズ・エルエルシー レチノール様活性を有する化合物及び加工オート麦成分を含む組成物
AU2024207487A1 (en) 2023-01-11 2025-07-03 Kenvue Brands Llc Skincare formulations comprising phenyl propionic acid derivatives and methods using same
WO2024150157A1 (en) 2023-01-11 2024-07-18 Johnson & Johnson Consumer Inc. Compositions suitable for use on sensitive skin and methods using same
FR3155714A1 (fr) 2023-11-24 2025-05-30 L V M H Recherche Association d’extraits de rose et peptide pour la nutrition de la peau
WO2026003722A1 (en) 2024-06-24 2026-01-02 Kenvue Brands Llc Compositions comprising compounds having retinol-like activity and an n-acetyl compound
WO2026003725A1 (en) 2024-06-24 2026-01-02 Kenvue Brands Llc Compositions comprising compounds having retinol-like activity and a polyhydroxy acid

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US255945A (en) * 1882-04-04 James denton
US1072666A (en) * 1912-08-07 1913-09-09 Frank Smith Nut-lock.
US2559459A (en) 1949-02-01 1951-07-03 Western Condensing Co Vegetable treatment process
US3849391A (en) * 1969-02-17 1974-11-19 Grain Processing Corp Recovery of protein
US3684520A (en) * 1969-12-09 1972-08-15 Us Agriculture Fractionation of leafy green crops
US3775133A (en) * 1971-08-02 1973-11-27 W Batley Fractionation of alfalfa wetted with molasses serum
US3821346A (en) * 1971-08-02 1974-06-28 W Batley Pet litter produced by recycled molasses serum
US3799806A (en) * 1972-04-20 1974-03-26 Danske Sukkerfab Process for the purification and clarification of sugar juices,involving ultrafiltration
US3823128A (en) * 1972-05-16 1974-07-09 Us Agriculture Preparation of edible protein from leafy green crops such as alfalfa
US4006078A (en) * 1974-07-08 1977-02-01 The United States Of America As Represented By The Secretary Of Agriculture Preparation of soluble edible protein from leafy green crops
US3959246A (en) * 1974-07-08 1976-05-25 The United States Of America As Represented By The Secretary Of Agriculture Preparation of soluble edible protein from leafy green crops
FR2294647A1 (fr) * 1974-11-04 1976-07-16 France Luzerne Procede de traitement de vegetaux verts feuillus en vue d'une extraction de proteines dans les jus de pressage et d'une deshydratation economique du tourteau
GB1430566A (en) 1974-11-15 1976-03-31 Nestel Sa Isolation of proteins
US3993794A (en) * 1976-01-15 1976-11-23 The United States Of America As Represented By The Secretary Of Agriculture Method for texturizing proteins
HU174943B (hu) * 1976-06-30 1980-04-28 Vepex Foevallalkozasi Iroda Rt Sposob poluchenija koncentratov rastitel'nogo belka i pigmenta
US4077950A (en) * 1976-07-12 1978-03-07 Source Proteins, Inc. Process for the recovery of substantially water-soluble non-toxic protein compounds from fresh non-woody vegetation
US4250197A (en) 1976-10-25 1981-02-10 Vepex Fovallalkopasi Iroda Rt. Method for processing plant protein
US4130553A (en) * 1977-01-05 1978-12-19 Batley Jr William R Process for improving the nutritional value of green plant protein
CA1099576A (en) * 1978-03-23 1981-04-21 Chester D. Myers Improved process for isolation of proteins
DE2816474A1 (de) * 1978-04-15 1979-10-25 Bayer Ag Dichlorbenzodioxolderivate, verfahren zu ihrer herstellung und ihre verwendung als synergisten in insektiziden und akariziden mitteln
US4234620A (en) * 1978-12-26 1980-11-18 A. E. Staley Manufacturing Company Water-soluble vegetable protein aggregates
GB2054343B (en) 1979-07-20 1983-08-24 Energiagazdalkodasi Intezet Preserving green vegetable matter
US4347324A (en) * 1979-09-24 1982-08-31 Leaf Proteins, Inc. Process for isolation of proteins from plant leaves
WO1982000569A1 (fr) * 1980-08-13 1982-03-04 Verniers C Procede d'obtention de jus clairs de vegetaux et de recuperation de constituants valorisables
US4359530A (en) * 1980-09-08 1982-11-16 Aluminum Company Of America Protein extraction from green crops
US4334024A (en) * 1980-11-03 1982-06-08 Sarjit Johal Preparation and crystallization of fraction I protein from plant sources
JPS5914451B2 (ja) 1981-03-09 1984-04-04 日本薬品開発株式会社 植物緑葉源抗炎症剤
US4333871A (en) * 1981-03-18 1982-06-08 International Harvester Company Coagulation method for preparing leaf protein concentrates (LPC) from plant foliage
US4421682A (en) * 1981-04-06 1983-12-20 The United States Of America As Represented By The Secretary Of Agriculture Heating of proteinaceous liquids
FR2523976B1 (fr) * 1982-03-26 1985-08-30 Pasteur Institut Nouveau produit proteique, obtention et application comme medicament, en particulier immunoregulateur et antiallergique
JPS59130173A (ja) * 1983-01-14 1984-07-26 Shiraimatsu Shinyaku Kk 飲料
SU1194361A1 (ru) * 1983-06-07 1985-11-30 Всесоюзный Научно-Исследовательский Институт Чайной Промышленности Способ производства ча
US4639375A (en) * 1983-08-12 1987-01-27 The Procter & Gamble Company Enzymatic treatment of black tea leaf
US4588691A (en) * 1984-02-29 1986-05-13 Johal Sarjit S Method for preparation of Fraction I protein and by-products thereof
US4897346A (en) * 1986-07-15 1990-01-30 Beckman Instruments, Inc. Stabilized liquid enzyme composition for glucose determination
CH671322A5 (enExample) * 1986-09-29 1989-08-31 Bucher Guyer Ag Masch
US4897345A (en) 1987-07-20 1990-01-30 Lubrizol Genetics Inc. Pollen tube growth assay
CN1039525A (zh) * 1988-05-19 1990-02-14 浙江农业大学 速溶茶加工工艺
FR2632308B1 (fr) * 1988-06-07 1991-08-16 Fondation Nale Transfusion San Procede et installation de fractionnement en continu de proteines vegetales animales ou humaines
JPH111686A (ja) 1990-05-14 1999-01-06 Yoshihide Hagiwara 抗酸化剤
US5723149A (en) * 1990-11-21 1998-03-03 Lvmh Recherche Use of medicago saponins for the preparation of cosmetic or pharmaceutical compositions, especially dermatological compositions, promoting renewal of the epidermis, stimulating hair regrowth or delaying hair loss
US6221363B1 (en) * 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
US5798446A (en) * 1991-10-10 1998-08-25 Nupron Gmbh Proteinwerk Method of extracting proteins utilizable in foodstuff from a protein-containing substance
JPH05229921A (ja) 1992-02-21 1993-09-07 Nakano Vinegar Co Ltd 発毛促進用組成物
JPH07112404B2 (ja) * 1992-05-08 1995-12-06 協同組合ティーライフクリエイティブ 緑茶の製茶方法
CH684924A5 (de) * 1993-04-02 1995-02-15 Bucher Guyer Ag Masch Verfahren zum Trennen fester und flüssiger Anteile, sowie Vorrichtung zu dessen Durchführung.
US5433968A (en) * 1993-04-23 1995-07-18 Nestec S.A. Process for producing a simulated meat product
US6068862A (en) * 1993-06-30 2000-05-30 Taiyo Kagaku Co., Ltd. Tea-derived feed additive and animal feed containing the same
US5777080A (en) * 1994-05-09 1998-07-07 The Board Of Trustees Of The University Of Arkansas Highly soluble protein, method for making, and food products made thereof
IT1275905B1 (it) * 1995-03-14 1997-10-24 Indena Spa Frazioni polifenoliche di te', loro uso e formulazioni che le contengono
AR002779A1 (es) * 1995-07-10 1998-04-29 Nestle Sa Procedimiento para fabricar una leche de almendras de frutas.
JPH09202726A (ja) * 1996-01-23 1997-08-05 Shiga Yoko 緑茶浴用剤
US5952023A (en) * 1996-02-05 1999-09-14 Lipton, Division Of Conopco, Inc. Enzyme extraction process for tea
CN1144652A (zh) * 1996-06-28 1997-03-12 青岛医学院附属专科医院 茶叶面膜
FR2751878B1 (fr) * 1996-07-30 1998-09-04 Oreal Utilisation dans une composition d'un extrait d'au moins une labiee
AU734341B2 (en) * 1996-08-02 2001-06-14 Shiseido Company Ltd. Composition for enhancing hyaluronic acid productivity and method for preparing same
IT1288257B1 (it) * 1996-11-29 1998-09-11 Paoli Ambrosi Gianfranco De Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico
US6037456A (en) * 1998-03-10 2000-03-14 Biosource Technologies, Inc. Process for isolating and purifying viruses, soluble proteins and peptides from plant sources
US5994508A (en) * 1998-04-13 1999-11-30 Protein Technologies International, Inc. Isoflavone rich protein isolate and process for producing
US6013771A (en) * 1998-06-09 2000-01-11 Protein Technologies International, Inc. Isoflavone rich protein isolate and process for producing
IT1301871B1 (it) * 1998-07-24 2000-07-07 Marlegreen Holding S A Procedimento per la produzione di te' in polvere o in foglia a ridotticosti di manodopera e di impianto
DK1002521T3 (da) * 1998-11-19 2002-11-11 Isernhagen Heilmittelbetr Gmbh Anvendelse af udtræk opnået ved ekstraktion med kuldioxid som deodoranter
KR20000033083A (ko) * 1998-11-19 2000-06-15 윤종용 컨버전스 조정장치 및 이에 적합한 컨버전스 조정방법
US6428818B1 (en) * 1999-03-30 2002-08-06 Purdue Research Foundation Tea catechin formulations and processes for making same
US6610749B2 (en) * 2000-02-18 2003-08-26 Arch Development Corporation Polyhydroxylated benzene-containing compounds
KR20010112817A (ko) * 2000-06-15 2001-12-22 황재관 녹차의 생리활성물질 분리방법
US6616952B1 (en) * 2000-11-17 2003-09-09 Roseberg Investments, Inc. Organic fungicide
KR100384308B1 (ko) * 2001-02-12 2003-05-14 노일섭 즉석 분말 인삼녹차 및 그 제조방법
KR100395464B1 (ko) * 2001-02-12 2003-08-25 노일섭 카테킨류의 신규한 추출방법 및 이를 이용한 카테킨 함유음료
JP4160276B2 (ja) * 2001-06-12 2008-10-01 株式会社 伊藤園 尿酸値低下剤及び尿酸値低下効果を備えた飲食物
CA2451844A1 (en) * 2001-06-27 2003-01-09 Unigen Pharmaceuticals, Inc. Method for generating, screening and dereplicating natural product libraries for the discovery of therapeutic agents
JP2003024010A (ja) * 2001-07-10 2003-01-28 Kenko Seikagaku:Kk 緑茶カテキンを主成分とする機能強化補助食品
KR20030030332A (ko) * 2001-10-09 2003-04-18 제주대학교 우묵사스레피의 추출물을 포함하는 항암용 조성물
JP2003171297A (ja) * 2001-12-07 2003-06-17 Ito En Ltd 血中ビリルビン濃度低下剤及び黄疸治療・予防剤
JP2003212771A (ja) * 2002-01-23 2003-07-30 Taiyo Kagaku Co Ltd 抗ナイセリア菌組成物
US7442391B2 (en) 2002-01-25 2008-10-28 Integrated Botanical Technologies, Llc Bioactive botanical cosmetic compositions and processes for their production
JP3590032B2 (ja) * 2002-04-17 2004-11-17 花王株式会社 緑茶ポリフェノールの製造法
WO2004080380A2 (fr) * 2003-03-05 2004-09-23 L'oreal Utilisation de polyphenols catechniques pour la preparation de compositions destinees a favoriser la pigmentation naturelle de la peau

Also Published As

Publication number Publication date
EP2491939B1 (en) 2017-09-20
AU2005206875B2 (en) 2010-06-24
EP1722805B1 (en) 2014-03-26
US7473435B2 (en) 2009-01-06
CN1929851A (zh) 2007-03-14
US10004777B2 (en) 2018-06-26
US20090185990A1 (en) 2009-07-23
WO2005069835A2 (en) 2005-08-04
AU2010221784A1 (en) 2010-10-07
HK1098675A1 (en) 2007-07-27
WO2005069835A3 (en) 2006-01-12
US20120045404A1 (en) 2012-02-23
US20120041059A1 (en) 2012-02-16
JP2007517907A (ja) 2007-07-05
NZ548718A (en) 2011-03-31
CN102327391B (zh) 2015-04-22
ES2652603T3 (es) 2018-02-05
PL1722805T3 (pl) 2014-08-29
CN1929851B (zh) 2012-06-27
KR101224697B1 (ko) 2013-01-21
AU2005206875A1 (en) 2005-08-04
US8318220B2 (en) 2012-11-27
US8043635B2 (en) 2011-10-25
ES2465949T3 (es) 2014-06-09
KR20060130176A (ko) 2006-12-18
BRPI0506751A (pt) 2007-06-12
EP1722805A2 (en) 2006-11-22
EP1722805A4 (en) 2009-08-26
US20140242009A1 (en) 2014-08-28
NZ598539A (en) 2013-09-27
MX342293B (es) 2016-09-23
BRPI0506751B1 (pt) 2019-12-31
JP2012136547A (ja) 2012-07-19
US20050181079A1 (en) 2005-08-18
EP2491939A1 (en) 2012-08-29
MXPA06007942A (es) 2007-02-16
JP5875896B2 (ja) 2016-03-02
CN102327391A (zh) 2012-01-25
CA2552710A1 (en) 2005-08-04
JP5276270B2 (ja) 2013-08-28
US20130146481A1 (en) 2013-06-13

Similar Documents

Publication Publication Date Title
BRPI0506751B8 (pt) método para isolar uma fração bioativa derivada de suco celular de uma planta de camellia sinensis
Chang et al. Antioxidant activity of extracts from Acacia confusa bark and heartwood
Seok et al. Punicalagin and (–)-epigallocatechin-3-gallate rescue cell viability and attenuate inflammatory responses of human epidermal keratinocytes exposed to airborne particulate matter PM10
BR112012016575A2 (pt) composição para cuidado da pele/dermatológica, fator de crescimento heterólogo produzido por planta, e, método para fabricar um produto tópico
BRPI0608796B8 (pt) método para a preparação de um extrato de planta compreendendo bacuquiol
BRPI0910874B8 (pt) formulação tópica para uso no tratamento tópico de uma condição da pele que resulta da produção de espécies reativas de oxigênio e/ou para a promoção da cicatrização de ferida tópica na pele de um indivíduo e uso da referida formulação
Lim et al. Stereoselective skin anti-photoaging properties of ginsenoside Rg3 in UV-B-irradiated keratinocytes
JP6907211B2 (ja) トケイソウ種子抽出物、およびそれを含有する化粧用、医薬用または皮膚科用の組成物
BRPI0511322A (pt) composições adequadas para o tratamento de sinais cutáneos provenientes do envelhecimento, tablete e formulação de tablete
KR101824770B1 (ko) 적하수오 부정근 추출물을 함유하는 피부 주름개선 기능성 화장료 조성물
US9839604B1 (en) Composition for an anti-aging treatment
US10537515B2 (en) Personal care composition and method of making the same
US10172787B2 (en) Method of regulating a condition of mammalian keratinous tissue
FR2884718B1 (fr) Composition cosmetique pour lutter contre les consequences cutanees de la pollution
Li et al. Lavender Exosome-Like nanoparticles attenuate UVB-Induced Photoaging via miR166-Mediated inflammation and collagen regulation
EP2482830B1 (en) Extracts of phyllanthus niruri
JP7481765B2 (ja) 薬品としての適用のためのモリンガ・ペレグリナ種子固形物のタンパク質加水分解物、それを得るための方法、並びに薬学的及び皮膚科学的組成物
WO2006117465A3 (fr) Utilisation de polyphenols de cacao pour reguler la pigmentation de la peau
KR101656928B1 (ko) 끈끈이여뀌 추출물을 유효성분으로 함유하는 광노화 방지 및 피부주름개선을 위한 조성물
AU2012203148A1 (en) Synergistic selenopeptide formulations for the protection of dermal papilla cells
Chalageri et al. Substituting plant vegetative parts with callus cell extracts: case study with Woodfordia fruticosa Kurz.–A potent ingredient in skin care formulations
WO2020138834A1 (ko) 조팝나무 추출물을 포함하는 피부질환 예방 또는 치료용 조성물
WO2024173954A3 (en) Therapeutic combinations for inflammatory conditions and disorders
WO2007008652A3 (en) Methods and compositions directed to dj-1 as regulator of the anti-oxidant transcription factor nrf2
BR112012009369A2 (pt) extrato vegetal padronizado, processo para preparação de extrato de plantas do gênero sclerolobium, composição cosmética, composição farmacêutica e uso do referido extrato

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B25A Requested transfer of rights approved

Owner name: AKZO NOBEL SURFACE CHEMISTRY LLC (US)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 31/12/2019, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/01/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2862 DE 11-11-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.